In cancer patients, studies have reported parallel elevation of both soluble molecules, PD-1 and PD-L1, in plasma suggesting they may have regulatory properties in order to counter the effect of each other as in the case of membrane-bound up-regulation (83–88). The gene discussed is CD274; the disease is cancer.